Thursday, March 15, 2012

Omega to pay GSK $614M to market Glaxo's OTC drugs - Triangle Business Journal

GlaxoSmithKline  (NYSE:GSK) has agreed to market some of its over-the-counter brands in Europe to Omega Pharma.

Belgium-based Omega Pharma is paying $614 million for brands such as stomach antacid Zantac and Nytol cold and allergy medicine .

Part of the deal includes transferring GSK’s Herrenberg, Germany factory to Omega Pharma.

Posted via email from Jack's posterous

No comments: